Question 1

What is the catalog number for Anti-FOLR1(mirvetuximab biosimilar) mAb?

Accepted Answer

The catalog number for Anti-FOLR1(mirvetuximab biosimilar) mAb is TA421331.

Question 2

What sizes are available for Anti-FOLR1(mirvetuximab biosimilar) mAb?

Accepted Answer

Anti-FOLR1(mirvetuximab biosimilar) mAb is available in the following size(s): 100 µg.

Question 3

Is Anti-FOLR1(mirvetuximab biosimilar) mAb in stock?

Accepted Answer

Anti-FOLR1(mirvetuximab biosimilar) mAb is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Anti-FOLR1(mirvetuximab biosimilar) mAb?

Accepted Answer

The safety data sheet for Anti-FOLR1(mirvetuximab biosimilar) mAb is available here: https://cdn.origene.com/sds/ta421331.pdf.

Question 5

What is Anti-FOLR1(mirvetuximab biosimilar) mAb used for?

Accepted Answer

Anti-FOLR1(mirvetuximab biosimilar) mAb

Question 6

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Question 7

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 8

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Anti-FOLR1(mirvetuximab biosimilar) mAb

Product Specifications

UniProt

Gene Location

Host

Reactivity

Clonality

Applications

Stability

Fragment

Symbol

Frequently Asked Questions

Explore Other Products

Erythropoietin (EPO) (Marker of Placentation Disorders) (EPO/3793R), CF405S conjugate, 0.1mg/mL

HLA-Pan (MHC II) (rHLA-Pan/3475), Biotin conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL

TACSTD2 / TROP2 (Epithelial Marker) (TACSTD2/2152), CF405S conjugate, 0.1mg/mL

CD47 (IAP/964), CF647 conjugate, 0.1mg/mL

Langerin / CD207 (Marker of Langerhans Cells) (rLGRN/1821), CF568 conjugate, 0.1mg/mL